Synsight Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 8

Employees

  • Latest Deal Type
  • M&A

Synsight General Information

Description

Developer of a drug discovery platform designed to combine artificial intelligence, molecular modeling and functional content screening. The company's platform specializes in molecular modeling, bioinformatics and structural biology to secure and efficiently new molecules, enabling clients to improve and accelerate their research.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 4 Rue Pierre Fontaine
  • 91058 Evry
  • France
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Corporate Office
  • 4 Rue Pierre Fontaine
  • 91058 Evry
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Synsight Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 08-Jul-2024 Completed Generating Revenue
4. Seed Round 29-Mar-2022 Completed Generating Revenue
3. Angel (individual) 06-Jul-2020 Completed Generating Revenue
2. Accelerator/Incubator 01-Mar-2013 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Synsight’s complete valuation and funding history, request access »

Synsight Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
To view Synsight’s complete cap table history, request access »

Synsight Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a drug discovery platform designed to combine artificial intelligence, molecular modeling and functional co
Drug Discovery
Evry, France
8 As of 2024

Paris, France
 

Paris, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Synsight Competitors (5)

One of Synsight’s 5 competitors is AQEMIA, a Venture Capital-Backed company based in Paris, France.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
AQEMIA Venture Capital-Backed Paris, France
Iktos Venture Capital-Backed Paris, France
Kvantify Venture Capital-Backed Copenhagen, Denmark
Ariana Pharma Formerly VC-backed Paris, France
POLARISqb Venture Capital-Backed Durham, NC
You’re viewing 5 of 5 competitors. Get the full list »

Synsight Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Synsight Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bpifrance Sovereign Wealth Fund Minority
Creative Destruction Lab Accelerator/Incubator
Health Innovation Hub Accelerator/Incubator
IncubAlliance Accelerator/Incubator Minority
University of Toronto University
You’re viewing 5 of 6 investors. Get the full list »

Synsight FAQs

  • When was Synsight founded?

    Synsight was founded in 2013.

  • Where is Synsight headquartered?

    Synsight is headquartered in Evry, France.

  • What is the size of Synsight?

    Synsight has 8 total employees.

  • What industry is Synsight in?

    Synsight’s primary industry is Drug Discovery.

  • Is Synsight a private or public company?

    Synsight is a Private company.

  • What is Synsight’s current revenue?

    The current revenue for Synsight is .

  • How much funding has Synsight raised over time?

    Synsight has raised $1.83M.

  • Who are Synsight’s investors?

    Bpifrance, Creative Destruction Lab, Health Innovation Hub, IncubAlliance, and University of Toronto are 5 of 6 investors who have invested in Synsight.

  • Who are Synsight’s competitors?

    AQEMIA, Iktos, Kvantify, Ariana Pharma, and POLARISqb are competitors of Synsight.

  • When was Synsight acquired?

    Synsight was acquired on 08-Jul-2024.

  • Who acquired Synsight?

    Synsight was acquired by Iktos.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process